Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.0B | 13.1B | 12.5B | 12.8B |
Cost of revenue | 4.3B | 5.7B | 5.4B | 5.9B |
Gross profit | 6.7B | 7.4B | 7.0B | 6.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.2B | 2.3B | 2.2B | 2.5B |
Operating income | 2.1B | 2.7B | 2.6B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 118.3M | 119.4M | 109.2M | 116.9M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 2.7B | 2.6B | 2.2B |
Tax provision | 546.7M | 703.1M | 672.1M | 572.4M |
Net income | 1.6B | 2.0B | 2.0B | 1.7B |
Basic EPS | — | 183.5 | 175.1 | 148.1 |
Diluted EPS | — | 183.5 | 175.1 | 148.1 |
Basic average shares | — | 11.2M | 11.2M | 11.2M |
Diluted average shares | — | 11.2M | 11.2M | 11.2M |
EBITDA | 2.6B | 3.2B | 3.0B | 2.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |